0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The impact of recreational marijuana commercialization on traumatic injury

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The medical legalization of marijuana has been shown to result in an increased risk of motor vehicle injuries. In Colorado, commercialization of recreational marijuana (initiation of retail sales) occurred on January 1, 2014, resulting in the rapid proliferation of its availability. The objective of this study was to determine whether the proportion of injured patients testing positive for marijuana and other drugs changed two years before and two years after commercialization of recreational marijuana in Colorado.

          Methods

          This retrospective multi-institutional cohort study included all patients admitted with a traumatic injury to six trauma centers (three centers in Colorado and three centers in states without permissive marijuana laws) from 2012 to 2015. The primary outcome was the rate (%) of a positive urine drug screen (UDS) for marijuana. Generalized linear regression models were used to examine the rate of change over time in the pre-commercialization period relative to the post- commercialization period (via an interaction effect), separately for states with and without recreational marijuana legalization.

          Results

          There were 40,591 trauma admissions. In Colorado, the rate of marijuana detected with UDS decreased over time pre-commercialization; this trend reversed post-commercialization, when marijuana detection rates increased significantly over time (interaction p = 0.004). At non-Colorado hospitals, the rate over time of marijuana detection was significantly reduced post-commercialization relative to the pre-commercialization period ( p <  0.001).

          Conclusion

          There was an overall increased rate over time of marijuana detected among trauma patients at Colorado hospitals but not at non-Colorado hospitals, suggesting an increased use of marijuana or an increased risk of injury while using marijuana following the commercialization of recreational marijuana in Colorado.

          Electronic supplementary material

          The online version of this article (10.1186/s40621-019-0180-4) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references16

          • Record: found
          • Abstract: found
          • Article: found

          Designing Difference in Difference Studies: Best Practices for Public Health Policy Research

          The difference in difference (DID) design is a quasi-experimental research design that researchers often use to study causal relationships in public health settings where randomized controlled trials (RCTs) are infeasible or unethical. However, causal inference poses many challenges in DID designs. In this article, we review key features of DID designs with an emphasis on public health policy research. Contemporary researchers should take an active approach to the design of DID studies, seeking to construct comparison groups, sensitivity analyses, and robustness checks that help validate the method's assumptions. We explain the key assumptions of the design and discuss analytic tactics, supplementary analysis, and approaches to statistical inference that are often important in applied research. The DID design is not a perfect substitute for randomized experiments, but it often represents a feasible way to learn about casual relationships. We conclude by noting that combining elements from multiple quasi-experimental techniques may be important in the next wave of innovations to the DID approach.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis

            Objective To determine whether the acute consumption of cannabis (cannabinoids) by drivers increases the risk of a motor vehicle collision. Design Systematic review of observational studies, with meta-analysis. Data sources We did electronic searches in 19 databases, unrestricted by year or language of publication. We also did manual searches of reference lists, conducted a search for unpublished studies, and reviewed the personal libraries of the research team. Review methods We included observational epidemiology studies of motor vehicle collisions with an appropriate control group, and selected studies that measured recent cannabis use in drivers by toxicological analysis of whole blood or self report. We excluded experimental or simulator studies. Two independent reviewers assessed risk of bias in each selected study, with consensus, using the Newcastle-Ottawa scale. Risk estimates were combined using random effects models. Results We selected nine studies in the review and meta-analysis. Driving under the influence of cannabis was associated with a significantly increased risk of motor vehicle collisions compared with unimpaired driving (odds ratio 1.92 (95% confidence interval 1.35 to 2.73); P=0.0003); we noted heterogeneity among the individual study effects (I2=81). Collision risk estimates were higher in case-control studies (2.79 (1.23 to 6.33); P=0.01) and studies of fatal collisions (2.10 (1.31 to 3.36); P=0.002) than in culpability studies (1.65 (1.11 to 2.46); P=0.07) and studies of non-fatal collisions (1.74 (0.88 to 3.46); P=0.11). Conclusions Acute cannabis consumption is associated with an increased risk of a motor vehicle crash, especially for fatal collisions. This information could be used as the basis for campaigns against drug impaired driving, developing regional or national policies to control acute drug use while driving, and raising public awareness.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Medical Marijuana Laws, Traffic Fatalities, and Alcohol Consumption

                Bookmark

                Author and article information

                Contributors
                christine.cmc@gmail.com
                Kristin.salottolo@icloud.com
                ahtannerii@gmail.com
                matt.carrick@acutesurgical.com
                RobertMadayag@Centura.Org
                gberg@kumc.edu
                mark.lieser@acutesurgical.com
                303-788-4089 , davidbme49@gmail.com
                Journal
                Inj Epidemiol
                Inj Epidemiol
                Injury Epidemiology
                Springer International Publishing (Cham )
                2197-1714
                4 February 2019
                4 February 2019
                December 2019
                : 6
                : 3
                Affiliations
                [1 ]ISNI 0000 0001 0503 5526, GRID grid.416782.e, Trauma Research Department, , Swedish Medical Center, ; Englewood, CO 80113 USA
                [2 ]GRID grid.430183.d, Trauma Research Department, , Penrose-St Francis Health Services, ; Colorado Springs, CO USA
                [3 ]Trauma Research Department, Medical City Plano, Plano, TX USA
                [4 ]GRID grid.490409.0, Trauma Research Department, , St. Anthony Hospital, ; Lakewood, CO USA
                [5 ]Trauma Research Department, Wesley Medical Center, Wichita, KS USA
                [6 ]ISNI 0000 0004 0415 2298, GRID grid.415884.4, Trauma Research Department, , Research Medical Center, ; MO, Kansas City, US USA
                Article
                180
                10.1186/s40621-019-0180-4
                6360194
                30714081
                a381dd51-a45b-472b-867f-2e24f74f95f9
                © The Author(s). 2019

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

                History
                : 19 November 2018
                : 11 January 2019
                Categories
                Original Contribution
                Custom metadata
                © The Author(s) 2019

                marijuana,legalization,activation,urine drug screen
                marijuana, legalization, activation, urine drug screen

                Comments

                Comment on this article